BiotechTube
Home/Cybrexa Therapeutics/Vishwas Paralkar, Ph.D.
VP

Vishwas Paralkar, Ph.D.

Chief Scientific Officer

Cybrexa Therapeutics

Therapeutic Areas

Oncology

Cybrexa Therapeutics Pipeline

DrugIndicationPhase
CBX-12Platinum-resistant or refractory ovarian cancerPhase 2